| Cell cycle deregulation in B-cell lymphomas M Sánchez-Beato, A Sánchez-Aguilera, MA Piris Blood, The Journal of the American Society of Hematology 101 (4), 1220-1235, 2003 | 507 | 2003 |
| Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study KH Young, K Leroy, MB Møller, GWB Colleoni, M Sánchez-Beato, ... Blood, The Journal of the American Society of Hematology 112 (8), 3088-3098, 2008 | 257 | 2008 |
| p53 and bcl-2 expression in high-grade B-cell lymphomas: correlation with survival time MA Piris, F Pezzella, JC Martinez-Montero, JL Orradre, R Villuendas, ... British Journal of Cancer 69 (2), 337-341, 1994 | 242 | 1994 |
| PLCG1 mutations in cutaneous T-cell lymphomas JP Vaqué, G Gómez-López, V Monsálvez, I Varela, N Martínez, C Pérez, ... Blood, The Journal of the American Society of Hematology 123 (13), 2034-2043, 2014 | 230 | 2014 |
| Analysis of the IgVH somatic mutations in splenic marginal zone lymphoma defines a group of unmutated cases with frequent 7q deletion and adverse clinical … P Algara, MS Mateo, M Sanchez-Beato, M Mollejo, IC Navas, L Romero, ... Blood, The Journal of the American Society of Hematology 99 (4), 1299-1304, 2002 | 207 | 2002 |
| 7q31-32 allelic loss is a frequent finding in splenic marginal zone lymphoma M Mateo, M Mollejo, R Villuendas, P Algara, M Sanchez-Beato, ... The American journal of pathology 154 (5), 1583-1589, 1999 | 173 | 1999 |
| Adverse clinical outcome in Hodgkin's disease is associated with loss of retinoblastoma protein expression, high Ki67 proliferation index, and absence of Epstein-Barr virus … MM Morente, MA Piris, V Abraira, A Acevedo, B Aguilera, C Bellas, ... Blood, The Journal of the American Society of Hematology 90 (6), 2429-2436, 1997 | 171 | 1997 |
| Molecular heterogeneity in MCL defined by the use of specificVH genes and the frequency of somatic mutations FI Camacho, P Algara, A Rodrıguez, E Ruız-Ballesteros, M Mollejo, ... Blood, The Journal of the American Society of Hematology 101 (10), 4042-4046, 2003 | 168 | 2003 |
| Progression to large B-cell lymphoma in splenic marginal zone lymphoma: a description of a series of 12 cases FI Camacho, M Mollejo, MS Mateo, P Algara, C Navas, JM Hernández, ... The American journal of surgical pathology 25 (10), 1268-1276, 2001 | 167 | 2001 |
| Loss of p16/INK4A protein expression in non-Hodgkin's lymphomas is a frequent finding associated with tumor progression R Villuendas, M Sánchez-Beato, JC Martínez, AI Saez, ... The American journal of pathology 153 (3), 887-897, 1998 | 156 | 1998 |
| Anomalous high p27/KIP1 expression in a subset of aggressive B-cell lymphomas is associated with cyclin D3 overexpression. p27/KIP1—cyclin D3 colocalization in tumor cells M Sánchez-Beato, FI Camacho, JC Martı́nez-Montero, AI Sáez, ... Blood, The Journal of the American Society of Hematology 94 (2), 765-772, 1999 | 154 | 1999 |
| Cancer induction by restriction of oncogene expression to the stem cell compartment M Pérez‐Caro, C Cobaleda, I González‐Herrero, C Vicente‐Dueñas, ... The EMBO journal 28 (1), 8-20, 2009 | 147 | 2009 |
| Cyclin-dependent kinase inhibitor p27KIP1 in lymphoid tissue: p27KIP1 expression is inversely proportional to the proliferative index. M Sanchez-Beato, AI Saez, JC Martinez-Montero, MS Mateo, ... The American journal of pathology 151 (1), 151, 1997 | 135 | 1997 |
| The expression of p53 protein in non-Hodgkin's lymphomas is not always dependent on p53 gene mutations R Villuendas, MA Piris, P Algara, M Sanchez-Beato, L Sánchez-Verde, ... | 130 | 1993 |
| Nodal marginal zone lymphoma: a heterogeneous tumor: a comprehensive analysis of a series of 27 cases FI Camacho, P Algara, M Mollejo, JF García, C Montalbán, N Martínez, ... The American journal of surgical pathology 27 (6), 762-771, 2003 | 127 | 2003 |
| Variability in the expression of polycomb proteins in different normal and tumoral tissues. A pilot study using tissue microarrays M Sánchez-Beato, E Sánchez, J González-Carreró, M Morente, A Díez, ... Modern pathology 19 (5), 684-694, 2006 | 113 | 2006 |
| MicroRNA signatures in B-cell lymphomas L Di Lisio, M Sánchez-Beato, G Gómez-López, ME Rodríguez, ... Blood cancer journal 2 (2), e57-e57, 2012 | 112 | 2012 |
| Nodal marginal zone lymphoma: gene expression and miRNA profiling identify diagnostic markers and potential therapeutic targets AJ Arribas, Y Campos-Martín, C Gómez-Abad, P Algara, ... Blood, The Journal of the American Society of Hematology 119 (3), e9-e21, 2012 | 106 | 2012 |
| PIM2 inhibition as a rational therapeutic approach in B-cell lymphoma C Gomez-Abad, H Pisonero, C Blanco-Aparicio, G Roncador, ... Blood, The Journal of the American Society of Hematology 118 (20), 5517-5527, 2011 | 106 | 2011 |
| Overall survival in aggressive B-cell lymphomas is dependent on the accumulation of alterations in p53, p16, and p27 M Sánchez-Beato, AI Sáez, IC Navas, P Algara, MS Mateo, R Villuendas, ... The American journal of pathology 159 (1), 205-213, 2001 | 105 | 2001 |
